Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Remote photobiomodulation improves brain injury outcomes and behavior in rats.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Clascoterone is safe for the heart, even at high doses.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Higher doses of Tribulus terrestris extract increase MC-1R expression in mouse hair follicles.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Baricitinib successfully treated severe hair loss.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Blocking interferon-gamma might help treat various autoimmune diseases.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Pinus densiflora extract may help improve memory and reduce brain inflammation.